Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nipro

Nipro
1954 FOUNDED
PUBLIC STATUS
30K-35K EMPLOYEES
8086 STOCK SYMBOL
19 INVESTMENTS
$11.83 SHARE PRICE (As of Tuesday Closing)
Description

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 3-9-3 Honjo-Nishi Kita-ku
  • Osaka, 531-8510
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nipro’s full profile, request a free trial.

Nipro Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$10.21 - $14.10 $1.93B $11.64 $0.58 600K 163M

Nipro Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 5,938,101 5,982,269 5,906,481 5,287,087
Revenue 4,005,131 3,845,828 3,566,859 3,319,739
EBITDA 549,379 562,697 505,065 513,467
Net Income 94,571 109,458 106,709 104,715
Total Assets 7,713,744 7,628,290 7,776,866 6,733,392
Total Debt 5,018,619 4,897,812 4,935,018 4,193,081
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nipro Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott Corporation North Chicago, IL 000000 000.00 000000000 000.00
00000000 Corporate Backed or Acquired Dublin, Ireland 0000 000000&0
000000 Corporate Backed or Acquired Holzkirchen, Germany 00000 00000000000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
To view this company’s complete list of competitors, request access »

Nipro Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 00000000 18-Jan-2017 00000 00000 00 00.000 Biotechnology
000000000 31-Oct-2015 000000000000000000 0000 Diagnostic Equipment 000000000 0000
0000 0000000 & 000 01-Mar-2014 000000000000000000 Biotechnology 000000000 0000
0000000 0000 00000 08-Jan-2014 000000000000000000 Diagnostic Equipment
Infraredx 22-Aug-2013 Later Stage VC 000.00 Diagnostic Equipment 000000000 0000
To view this company’s complete investment and acquisition history, request access »

Nipro Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000 15-Mar-2010 000000000000000000 00000 Completed
  • 00000
000000000 07-Oct-2008 00000 00000 00 00.000 Completed
  • 5 buyers
Bipha 01-Feb-2001 Secondary Transaction - Private Completed
To view this company’s complete exits history, request access »

Nipro Subsidiaries (6)

Company Name Industry Location Founded
Cell Science & Technology Institute Biotechnology Aoba-ku, Japan 2001
000000000 Diagnostic Equipment Burlington, MA 0000
00000 000000 Acquirer Mechelen, Belgium 0000
0.0. 00000 Pharmaceuticals Lancaster, NH 0000
00000 000 000000 Distributors (Healthcare) Dhaka, Bangladesh
To view this company’s complete subsidiary history, request access »

Nipro Executive Team (2)

Name Title Board
Seat
Contact
Info
Yoshihiko Sano President and Representative Director

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »